Zheng Quan Shi Bao·2025-04-21 04:40Market Overview - The A-share market showed overall strength in the morning session, with major indices rising to varying degrees. The Shanghai Composite Index increased by 0.3%, the Shenzhen Component Index rose by 0.72%, and the ChiNext Index gained 1.05% [2][4]. Cross-Border E-commerce Sector - The cross-border e-commerce concept stocks surged, leading to a wave of stocks hitting the daily limit. Notable stocks that reached the limit within the first five minutes of trading include Xinghui Co., Ltd. (300464), Kuaijingtong (002640), and Jiuqi Software (002279) [2][6]. Gold Market - Domestic gold futures prices broke through 800 yuan per gram for the first time, driving significant gains in gold-related stocks. The gold concept stocks saw a substantial rise, particularly gold mining stocks, with notable increases in companies like Xiaocheng Technology (300139) and Chaohongji (002345) [3][9][11]. ETF Performance - Several Hong Kong Stock Connect ETFs experienced significant gains, with the Hong Kong Stock Connect 100 ETF (159788) rising over 10% during the session. Other related ETFs also saw increases exceeding 5% [6]. Company Financial Performance - Cambrian Biologics (寒武纪-U) reported a revenue of 1.174 billion yuan for 2024, marking a year-on-year increase of 65.56%. The gross profit totaled 666 million yuan, up 35.77% from the previous year. The company narrowed its net loss to 865 million yuan, a reduction of 178 million yuan compared to the previous year [13][15]. - In the first quarter of 2025, Cambrian Biologics achieved a revenue of 1.111 billion yuan, reflecting a staggering year-on-year growth of 4230.22%, and turned a profit with a net income of 355 million yuan [15].